Friday - July 18, 2025
Rutgers: Triple Therapy Halved the Risk of Death Among Patients Hospitalized With Severe COVID-19
August 09, 2022
NEW BRUNSWICK, New Jersey, Aug. 9 (TNSres) -- Rutgers University issued the following news:

Hospitalized patients on high-flow oxygen for severe COVID-19 pneumonia were nearly 50 percent less likely to die when baricitinib was added to the antiviral remdesivir and the steroid dexamethasone, according to Rutgers research.

"All three of the medications work in different ways, so it makes sense that you'd get added therapeutic benefit by combining them," sai . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation
Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products